Table 1.
Patient Characteristics | |
---|---|
Median age, IQR | 57 [37, 70] |
Female Sex (n, %) | 52 (54) |
Race (n, %) | |
White | 88 (92) |
African American | 3 (3) |
Hispanic | 3 (3) |
Other/Unknown | 2 (2) |
Comorbidities (n, %) | |
Hypertension | 50 (52) |
Diabetes Mellitus | 32 (33) |
Coronary or peripheral vascular disease | 27 (28) |
Chronic kidney disease | 23 (24) |
Intravenous drug use | 17 (18) |
Atopy | 12 (13) |
Hepatitis C infection | 11 (11) |
HIV infection | 4 (4) |
Any drug allergy history | 63 (66) |
Penicillin allergy history | 20 (21) |
Cephalosporin allergy history | 13 (14) |
| |
Treatment Characteristics | |
| |
Doses of ceftaroline, Median [IQR] | 28 [6–63] |
Days of ceftaroline, Median [IQR] | 13 [4–30] |
Concomitant or sequential antibiotic use (n, %) | |
Daptomycin | 14 (14) |
Vancomycin | 10 (10) |
Rifampin | 6 (6) |
Linezolid | 5 (5) |
Other * | 43 (44) |
Infectious Diagnosis (n, %)† | |
Bacteremia | 34 (35) |
Orthopedic infections‡ | 27 (28) |
Skin/soft tissue infections | 27 (28) |
Pneumonia/empyema | 21 (22) |
Endocarditis | 14 (15) |
Vascular graft infection | 8 (8) |
Intra-abdominal infections | 2 (2) |
Epidural abscess | 1 (1) |
Patients Treated Off-Label | 57 (59) |
Organism (n, %) | |
MRSA | 52 (54) |
CoNS | 10 (10) |
MSSA | 5 (5) |
Other || | 9 (9) |
Not identified or recovered | 20 (21) |
Other includes azithromycin, cefazolin, cefepime, ceftazidine, ciprofloxacin, clindamycin, colistin, doxycycline, fluconazole, imipenem, inhaled tobramycin, levofloxacin, meropenem, metronidazole, micafungin, moxifloxacin, nafcillin, piperacillin-tazobactam, and trimethroprim-sulfamethoxazole.
Of the patients with a primary infectious diagnosis of bacteremia some patients also had a secondary diagnosis of endocarditis (n=2), intra-abdominal infection (n=2), pneumonia (n=1); of the with primary orthopedic infections some patients also had a secondary diagnosis of bacteremia (n=8); of the patients with a primary diagnosis of skin and soft tissue infection some patients also had a secondary diagnosis of bacteremia (n=2), pneumonia (n=1), orthopedic (n=2); of the patients with a primary infectious diagnosis of pneumonia some patients also had a secondary diagnosis of bacteremia (n=2); of the patients with a primary diagnosis of endocarditis some patients also had a secondary diagnosis of bacteremia (n=5), pneumonia (n=4), vascular (n=1); of the patients with a primary diagnosis of vascular infection some patients also had a secondary diagnosis of bacteremia (n=2), pneumonia (n=1)
Orthopedic infections include osteomyelitis, prosthetic joint infections, septic arthritis, post-operative spine infections, and infections after fracture/fixation
Includes Pseudomonas aeruginosa (n=2), Enterobacter aerogenes (n=1), Klebsiella pneumoniae (n=1), Candida albicans (n=1), Enterococcus faecalis (n=1), Staphylococcus lugdunensis (n=1), Beta-hemolytic Streptococcus (n=1), Streptococcus pneumoniae (n=1)
Abbreviations: HIV: Human Immunodeficiency Virus, MRSA: Methicillin-resistant Staphylococcus aureus, CoNS: Coagulase-negative Staphylococcus, MRSA: Methicillin-sensitive Staphylococcus aureus